Patients News | pharmaphorum

News

A globe atlas from above on a white surface

Novartis issues a life sciences warning in a 'G-Zero' world

Novartis claims life sciences lie at the centre of a shift in geopolitics and policies in regions like Europe, Japan, and Canada are "self-defeating."

News

FDA seeks changes to GLP-1, flu shot labels

The FDA has asked manufacturers of GLP-1 drugs used for weight loss to remove warnings of suicidal thinking, but added warnings to flu shots.

News

JPM: Anthropic reveals its answer to ChatGPT for Health

Anthropic has launched Claude for Healthcare, a suite of AI tools designed for health systems, payers, and patients.

News

Sentynl gets first FDA approval for rare disease Menkes

Children with a devastating, rare disorder of copper metabolism, called Menkes disease, now have an FDA-approved treatment for the first time.

News

JPM: Is the UK's clinical trials sector turning a corner?

New data from the UK medicines regulator has shown an increase in clinical trial activity in the country, after years of decline.

News

FDA removes barriers to cell, gene therapy development

FDA wants to exert regulatory flexibility on cell and gene therapies in an effort to bring them to patients more quickly and efficiently.

Novartis issues a life sciences warning in a 'G-Zero' world

FDA seeks changes to GLP-1, flu shot labels

JPM: Anthropic reveals its answer to ChatGPT for Health

Sentynl gets first FDA approval for rare disease Menkes

JPM: Is the UK's clinical trials sector turning a corner?

FDA removes barriers to cell, gene therapy development

ESC26: Isomab safety evidence on blood vessel growth for CAD

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks